Morning Overview on MSN
Billionaires chase immortality as Harvard-backed startup wins FDA nod for 1st partial de-aging trial
The race to slow, halt, or even reverse aging has moved from science fiction into the regulatory record. A Harvard-linked startup, Life Biosciences, has secured clearance from the U.S. Food and Drug ...
An official document shows that since spring last year, ICE has relied on an AI-powered system to process information sent to its tip line.
Henderson, NV - January 16, 2026 - PRESSADVANTAGE - Las Vegas Eye Institute announces the integration of Ray-Traced ...
OpenAI, the company best known for its AI applications like ChatGPT and Sora, is reportedly working on a social media network ...
The FDA approved a fixed-dose combination of carbachol and brimonidine tartrate for presbyopia, offering a noninvasive ...
Biometric trackers, cellphone location databases and drones are among the surveillance technologies agents are using in their immigration enforcement campaign.
OpenAI explores biometric social verification using iris-scanning and face ID on its new platform, sparking a 25% rise in ...
YUVEZZI (TM) (carbachol and brimonidine tartrate ophthalmic solution) 2.75%/0.1% is a dual-agent eye drop approved by the U.S. Food & Drug Administration (FDA) for the treatment of presbyopia, a ...
Enrollment includes collecting biographical details and face, iris and fingerprint biometrics from registrants to create a ...
The new Global ID patent illustrates a system that reads finger vein patterns in 3D to provide biometric access to ...
The Hampton Sheriff’s Office announced a partnership with Bravado Engineering to pilot a new biometric monitoring system for ...
ARKI kicked off with a panel on nine self-service trends to keep an eye on in the coming years: including computer vision, cobots and more.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results